UBS Group Portfolio holdings
UBS Group is the Swiss bank holding company behind UBS, which was created in 1998 when Union Bank of Switzerland merged with Swiss Bank Corporation; the holding company was listed in New York in 2014. Its business spans wealth management, investment banking, asset management and banking for individuals and companies. Its asset management arm offers stock, bond, currency, hedge fund, real estate, infrastructure and private equity strategies, which can also be combined in multi-asset portfolios. The group's roots go back to the Bank in Winterthur, founded in 1862, and to Swiss Bank Corporation, started by six private bankers in Basel by 1854. The wealth management arm serves high net worth individuals worldwide, and its US business grew out of Paine Webber, the American brokerage UBS merged with in 2000 and renamed UBS Wealth Management USA in 2003. In 2023 UBS took over Credit Suisse in a rescue deal arranged by the Swiss government and central bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.15B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$611M |
| 3 |
SpaceX
SPCX
|
+$567M |
| 4 |
Apple
AAPL
|
+$511M |
| 5 |
Jabil
JBL
|
+$463M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.49B |
| 2 |
Western Digital
WDC
|
+$1.42B |
| 3 |
Lumentum
LITE
|
+$951M |
| 4 |
Intel
INTC
|
+$785M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$749M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.93% |
| 2 | Technology | 18.61% |
| 3 | Financials | 7.85% |
| 4 | Industrials | 6.96% |
| 5 | Healthcare | 5.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2101
Credicorp
BAP
$27.9B
| $34.8M | ﹤0.01% |
89,328
+15,353
| +21% | +$5.25M |
2014 Q4
46 quarters
|
|
2102
NuScale Power
SMR
$2.11B
| $34.7M | ﹤0.01% |
3,464,576
+858,834
| +33% | +$9.7M |
2022 Q2
16 quarters
|
|
2103
Xtrackers S&P 500 ESG ETF
SNPE
$2.89B
| $34.7M | ﹤0.01% |
504,618
-7,690
| -2% | -$510K |
2020 Q2
24 quarters
|
|
2104
Bread Financial
BFH
$3.98B
| $34.7M | ﹤0.01% |
319,836
-115,429
| -27% | -$10.4M |
2014 Q4
46 quarters
|
|
2105
Belite Bio
BLTE
$6.2B
| $34.6M | ﹤0.01% |
224,989
-543,370
| -71% | -$83.3M |
2024 Q3
7 quarters
|
|
2106
OneMain Financial
OMF
$6.48B
| $34.6M | ﹤0.01% |
568,157
+117,735
| +26% | +$6.63M |
2014 Q4
46 quarters
|
|
2107
Calamos Convertible Opportunities and Income Fund
CHI
$869M
| $34.6M | ﹤0.01% |
2,574,530
+196,134
| +8% | +$2.42M |
2014 Q4
46 quarters
|
|
2108
Oscar Health
OSCR
$10.9B
| $34.6M | ﹤0.01% |
1,213,056
-361,922
| -23% | -$7.79M |
2021 Q2
20 quarters
|
|
2109
H&R Block
HRB
$6.79B
| $34.6M | ﹤0.01% |
908,285
-26,410
| -3% | -$920K |
2014 Q4
46 quarters
|
|
2110
Hycroft Mining Holding Corp
HYMC
$1.63B
| $34.5M | ﹤0.01% |
1,476,357
+982,974
| +199% | +$33.2M |
2022 Q4
14 quarters
|
|
2111
CALL
Peloton Interactive
PTON
$2.4B
| $34.5M | ﹤0.01% |
5,838,462
+1,740,312
| +42% | +$9.39M |
2022 Q3
15 quarters
|
|
2112
CALL
Lam Research
LRCX
$277B
| $34.5M | ﹤0.01% |
79,600
-63,100
| -44% | -$19.2M |
2021 Q2
20 quarters
|
|
2113
Sportradar
SRAD
$4.29B
| $34.5M | ﹤0.01% |
2,303,577
-1,500,782
| -39% | -$21.8M |
2021 Q3
19 quarters
|
|
2114
Davis Select US Equity ETF
DUSA
$1.29B
| $34.5M | ﹤0.01% |
613,239
+22,465
| +4% | +$1.24M |
2018 Q1
33 quarters
|
|
2115
Popular Inc
BPOP
$9.9B
| $34.4M | ﹤0.01% |
209,463
-233,420
| -53% | -$35.2M |
2014 Q4
46 quarters
|
|
2116
Nuveen Preferred & Income Opportunities Fund
JPC
$2.66B
| $34.4M | ﹤0.01% |
4,361,872
-37,322
| -0.8% | -$293K |
2014 Q4
46 quarters
|
|
2117
Merit Medical Systems
MMSI
$5.04B
| $34.4M | ﹤0.01% |
495,598
+154,972
| +45% | +$10.2M |
2014 Q4
46 quarters
|
|
2118
iShares MSCI World ETF
URTH
$9.17B
| $34.3M | ﹤0.01% |
169,197
-12,638
| -7% | -$2.5M |
2014 Q4
46 quarters
|
|
2119
WisdomTree US Quality Growth Fund
QGRW
$3.18B
| $34.1M | ﹤0.01% |
516,476
-10,888
| -2% | -$687K |
2023 Q2
12 quarters
|
|
2120
CALL
State Street Health Care Select Sector SPDR ETF
XLV
$49.9B
| $34M | ﹤0.01% |
214,516
-985,900
| -82% | -$147M |
2014 Q4
46 quarters
|
|
2121
PUT
Bristol-Myers Squibb
BMY
$131B
| $34M | ﹤0.01% |
590,500
+374,500
| +173% | +$21.5M |
2014 Q4
46 quarters
|
|
2122
BlackRock Science and Technology Term Trust
BSTZ
$1.76B
| $34M | ﹤0.01% |
1,132,868
-70,494
| -6% | -$1.95M |
2019 Q2
28 quarters
|
|
2123
Invesco Large Cap Value ETF
PWV
$1.88B
| $34M | ﹤0.01% |
448,413
-16,668
| -4% | -$1.23M |
2014 Q4
46 quarters
|
|
2124
NovaGold Resources
NG
$2.68B
| $34M | ﹤0.01% |
5,687,434
+1,356,843
| +31% | +$11.3M |
2014 Q4
46 quarters
|
|
2125
argenx
ARGX
$56.7B
| $33.9M | ﹤0.01% |
36,583
+4,936
| +16% | +$4.07M |
2017 Q4
34 quarters
|
|
Similar funds
UBS Group's Q2 2026 Portfolio in Review
As of Q2 2026, UBS Group held 11,684 positions worth $786B, up 18% from $666B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q2 2026 filing shows 1,281 new, 4,217 increased, 4,362 reduced and 1,275 closed positions. Its largest new stake was Honeywell Aerospace: 2,768,136 shares worth $612M. The largest sale was ExxonMobil, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 39% a quarter earlier, followed by Technology and Financials.
- UBS Group's largest Q2 2026 buy was Honeywell Aerospace: 2,768,136 shares worth $612M.
- UBS Group added most to Microsoft in Q2 2026, an estimated $1.15B increase.
- UBS Group's biggest Q2 2026 reduction was ExxonMobil, cutting an estimated $1.49B.
- UBS Group fully exited Hologic in Q2 2026, selling an estimated $385M.
- UBS Group's ten largest holdings make up 13% of its $786B portfolio in Q2 2026.
- UBS Group opened 1,281 new positions and closed 1,275 in Q2 2026.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $786B.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.